Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04136977 · ClinicalTrials.gov registry record
XprESS ET Registry
A clinical trial, sponsored by Entellus Medical.
- Completed
- Registry status
- 169
- Enrollment target
NCT04136977: Completed study, sponsored by Entellus Medical.
NCT04136977 is a clinical trial that has completed, run by Entellus Medical. The registered enrollment target is 169 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04136977 has completed, sponsored by Entellus Medical.
- COMPLETED
- Registry status
- 169 participants
- Enrollment target
Study Summary
A prospective, multicenter, registry of patients undergoing balloon dilation of the Eustachian tubes (ET).
Primary Outcome
Change from baseline to follow-up in the mean overall ETDQ-7 score. The ETDQ-7 is a validated 7-item patient-reported questionnaire reporting the presence and severity of symptoms associated with Eustachian tube dysfunction. Each item is scored from 1 (normal) to 7 (severe). The overall score is the mean score of the 7 items.
Interventions
- DEVICE Eustachian tube dilation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2018-06-05 |
| Est. Completion | 2020-08-28 |
What the finished NCT04136977 record still lists
NCT04136977 is an observational study that tracks outcomes without assigning an intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Eustachian tube dilation is the first listed.
NCT04136977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04136977 about?
NCT04136977 is a clinical study titled "XprESS ET Registry". A prospective, multicenter, registry of patients undergoing balloon dilation of the Eustachian tubes (ET).
What is the current status of trial NCT04136977?
This trial is currently completed. The enrollment target is 169 participants. The study started on 2018-06-05. Estimated completion is 2020-08-28.
What interventions are being tested in trial NCT04136977?
The interventions under investigation include: Eustachian tube dilation (DEVICE).
Who is sponsoring clinical trial NCT04136977?
This trial is sponsored by Entellus Medical, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI